Event category: Concurrent Session
Events
September 04, 2025
04:30 PM (EDT)
- 05:15 PM (EDT)
Clinical Workflow: Interoperability, Decision-Making, and Solutions – What’s the Missing Link?
Clinical Workflow: Interoperability, Decision-Making, and Solutions – What’s the Missing Link?
David Slotwiner
This session explores how AI integration, EMR advancements, and remote monitoring can enhance physician decision-making, streamline workflows, and improve patient care. Panelists will discuss the impact of AI on billing and physician hours, the role of device-driven insights in heart failure management, and how RNs and APPs contribute to effective communication and data management. Join us for an insightful discussion on leveraging technology to optimize clinical efficiency and patient outcomes.
04:30 PM (EDT)
- 05:15 PM (EDT)
AI at the Point of Care: Redesigning Documentation for Clinicians
AI at the Point of Care: Redesigning Documentation for Clinicians
Dhanunjaya R. Lakkireddy
From dictation software to full-blown natural language processing assistants, AI-based documentation tools promise to free clinicians from the tedium of charting. Physician burnout is on the rise—can AI-driven documentation help turn the tide? Strategies for successful change management, physician buy-in, and ongoing system optimization will be highlighted. How do we ensure data accuracy, privacy, and seamless integration into diverse electronic health records? Panelists will discuss the practical implementation of AI-assisted documentation and patient communication, while maintaining patient-centered care.
03:45 PM (EDT)
- 04:30 PM (EDT)
Novel Molecular and Genetic Therapies for Inherited Arrhythmia Syndrome and Arrhythmogenic Cardiomyopathies
Novel Molecular and Genetic Therapies for Inherited Arrhythmia Syndrome and Arrhythmogenic Cardiomyopathies
Dominic Abrams
Inherited arrhythmia syndromes and cardiomyopathies pose a significant clinic challenge, with suboptimal treatment and a large unmet need. Over the last decade several new therapies have been developed which target the underlying genetic and molecular causes of these conditions, and many are progressing from pre-clinical research to clinical trials. These discoveries offer a potential paradigm shift in treatment strategies and quality of life for patients. This panel focused on novel genetic and molecular therapies for inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies will bring together experts with a broad range of experience including venture capital, clinicians, translational scientists, and biotech. The session will address a wide range of topics from lab discovery to commercialization.
02:45 PM (EDT)
- 03:30 PM (EDT)
Pediatric EP and Cardiac Tech: Lifesaver or Just the Start?
Pediatric EP and Cardiac Tech: Lifesaver or Just the Start?
Brynn Dechert-Crooks
From life-changing interventions to emotional uncertainties, how does cardiac technology shape the journey of children and young adults with arrhythmias? This session explores the evolving role of electrophysiology (EP) in pediatrics, the impact of cutting-edge devices, and the patient experience—balancing fear, hope, and the promise of innovation. Are we maximizing technology’s potential, or is is there more to uncover in improving outcomes and quality of life for young patients?
02:00 PM (EDT)
- 02:45 PM (EDT)
AFib, AI, and the Future of Care: Revolution or Just Hype?
AFib, AI, and the Future of Care: Revolution or Just Hype?
Mintu Turakhia
This session explores how AI-driven innovations are transforming atrial fibrillation (AF) management, from prevention to long-term care. Experts will discuss AI-powered digital education, solutions for early intervention, and technology’s role in addressing key risk factors like obesity, sleep apnea, and exercise. Is AI the game-changer in achieving sustainable AF care, or just another trend? Join us to find out.